Literature DB >> 9050124

The life course of schizophrenia: age and symptom dimensions.

S K Schultz1, D D Miller, S E Oliver, S Arndt, M Flaum, N C Andreasen.   

Abstract

The life course of schizophrenia has eluded description for several reasons, including fluctuations in diagnostic criteria over the past century, and dramatic changes in treatment and expectations of the mentally ill. This study compared symptoms within a group of patients spanning ages 14 through 73. The three symptom dimensions (psychotic, disorganized and negative) were examined separately in relation to age. Using a multivariate analysis, the effects of age, sex and institutional status were found to have main effects for symptom severity with no interaction effects. The effect of age was significant in the negative direction for positive and disorganized symptoms. Age was specifically associated with decreased hallucinations, delusions, bizarre behavior and inappropriate affect. There was no age effect for formal thought disorder, nor was there an age effect for negative symptoms. Institutionalization was associated with greater symptom severity in all dimensions. Male gender was associated with greater severity of negative symptoms. We conclude that psychotic and disorganized symptoms are likely to be of lesser severity in older patients with schizophrenia, while negative symptoms tend to persist. Clinically, these findings suggest that medications targeting negative symptoms may confer the greatest benefit in treating the older patient with schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9050124     DOI: 10.1016/S0920-9964(96)00087-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

Review 1.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

2.  Effects of age on white matter integrity and negative symptoms in schizophrenia.

Authors:  Kelly Rowe Bijanki; Brendan Hodis; Vincent A Magnotta; Eugene Zeien; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2014-06-20       Impact factor: 4.939

Review 3.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

4.  Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study.

Authors:  Gagan Fervaha; Fernando Caravaggio; David C Mamo; Benoit H Mulsant; Bruce G Pollock; Shinichiro Nakajima; Philip Gerretsen; Tarek K Rajji; Wanna Mar; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Gary Remington; Ariel Graff-Guerrero
Journal:  Psychopharmacology (Berl)       Date:  2016-08-24       Impact factor: 4.530

5.  The symptoms of autism spectrum disorders in adolescence and adulthood.

Authors:  Marsha Mailick Seltzer; Marty Wyngaarden Krauss; Paul T Shattuck; Gael Orsmond; April Swe; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2003-12

6.  Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery.

Authors:  Linda S Grossman; Martin Harrow; Cherise Rosen; Robert Faull; Gregory P Strauss
Journal:  Compr Psychiatry       Date:  2008-06-03       Impact factor: 3.735

7.  Comparing schizophrenia symptoms in the Iban of Sarawak with other populations to elucidate clinical heterogeneity.

Authors:  Duncan McLean; Robert Barrett; Peter Loa; Rangaswamy Thara; Sujit John; John McGrath; Jake Gratten; Bryan Mowry
Journal:  Asia Pac Psychiatry       Date:  2013-08-22       Impact factor: 2.538

8.  Normal sexual dimorphism in theory of mind circuitry is reversed in Schizophrenia.

Authors:  Julie Walsh-Messinger; Christine Stepanek; Julia Wiedemann; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  Soc Neurosci       Date:  2018-10-29       Impact factor: 2.083

9.  Decreased default mode neural modulation with age in schizophrenia.

Authors:  Christopher C Abbott; Dae Kim; Scott R Sponheim; Juan Bustillo; Vince D Calhoun
Journal:  Am J Geriatr Psychiatry       Date:  2010-10       Impact factor: 4.105

10.  The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.